+ND Capital

Aymeric founded +ND Capital in 2002. He discovered the nanotechnology world while conducting research between the Physics and Chemistry departments of EPFL in the 90’s. He was convinced that significant breakthroughs would arise at the nanoscale and extensive expertise would be required to differentiate science from science fiction. This was the foundation of +ND Capital. Following the raise of the first ND partnership, Aymeric realized that despite great science in Europe, the US was offering b

Eric joined +ND Capital in 2008 and was the first employee of our Silicon Valley office. He is focused on life sciences investments. Eric is currently a board member of Emulate, Visby Medical, AIRNA, Partillion, Osasuna and a board observer of Lightcast, IonPath and Inscripta. He was previously a board member of Icosavax (Acquired by AZ), Serotiny (Acquired by J&J), SQZ Biotech (NYSE: SQZ), and observed on the boards of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Eric also helped lead +ND

Jonathan joined +ND Capital in 2005 and is based in our Grand Cayman office. He is the former Managing Director of Merrill Lynch Bank & Trust Company and Head of Corporate Management at KPMG in the Cayman Islands. He has an extensive background as a director of several important and sizeable investment entities.

Kirill joined +ND Capital in our Silicon Valley office in 2013. He is focused on physical science investments and is currently a board observer of SiMa.ai and Spark Microsystems.

+ND Capital (f.k.a. NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences. Our core belief is that scientific disciplines will continue to converge, and that some of the biggest breakthroughs will be based on this convergence. We invest across the United States and Europe, and through our teams in Silicon Valley, Switzerland and the Cayman Islands, we can help our portfolio companies bridge the Atlantic to at